BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8263913)

  • 1. Conformational variability of chicken cystatin. Comparison of structures determined by X-ray diffraction and NMR spectroscopy.
    Engh RA; Dieckmann T; Bode W; Auerswald EA; Turk V; Huber R; Oschkinat H
    J Mol Biol; 1993 Dec; 234(4):1060-9. PubMed ID: 8263913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structures of native phosphorylated chicken cystatin and of a recombinant unphosphorylated variant in solution.
    Dieckmann T; Mitschang L; Hofmann M; Kos J; Turk V; Auerswald EA; Jaenicke R; Oschkinat H
    J Mol Biol; 1993 Dec; 234(4):1048-59. PubMed ID: 8263912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The solution structure of bovine ferricytochrome b5 determined using heteronuclear NMR methods.
    Muskett FW; Kelly GP; Whitford D
    J Mol Biol; 1996 Apr; 258(1):172-89. PubMed ID: 8613986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR structural studies of human cystatin C dimers and monomers.
    Ekiel I; Abrahamson M; Fulton DB; Lindahl P; Storer AC; Levadoux W; Lafrance M; Labelle S; Pomerleau Y; Groleau D; LeSauteur L; Gehring K
    J Mol Biol; 1997 Aug; 271(2):266-77. PubMed ID: 9268658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
    Tate S; Ushioda T; Utsunomiya-Tate N; Shibuya K; Ohyama Y; Nakano Y; Kaji H; Inagaki F; Samejima T; Kainosho M
    Biochemistry; 1995 Nov; 34(45):14637-48. PubMed ID: 7578072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
    J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the structure of oxidised Desulfovibrio africanus ferredoxin I by 1H NMR spectroscopy and comparison of its solution structure with its crystal structure.
    Davy SL; Osborne MJ; Moore GR
    J Mol Biol; 1998 Apr; 277(3):683-706. PubMed ID: 9533888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human interleukin-4 and variant R88Q: phasing X-ray diffraction data by molecular replacement using X-ray and nuclear magnetic resonance models.
    Müller T; Oehlenschläger F; Buehner M
    J Mol Biol; 1995 Mar; 247(2):360-72. PubMed ID: 7707380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain.
    Díaz BG; Gross S; Assfalg-Machleidt I; Pfeiler D; Gollmitzer N; Gabrijelcic-Geiger D; Stubbs MT; Fritz H; Auerswald EA; Machleidt W
    Biol Chem; 2001 Jan; 382(1):97-107. PubMed ID: 11258679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
    Pol E; Björk I
    Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal protein L9: a structure determination by the combined use of X-ray crystallography and NMR spectroscopy.
    Hoffman DW; Cameron CS; Davies C; White SW; Ramakrishnan V
    J Mol Biol; 1996 Dec; 264(5):1058-71. PubMed ID: 9000630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR structure of the cathelin-like domain of the protegrin-3 precursor.
    Yang Y; Sanchez JF; Strub MP; Brutscher B; Aumelas A
    Biochemistry; 2003 Apr; 42(16):4669-80. PubMed ID: 12705830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
    Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
    Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR solution structure of a synthetic troponin C heterodimeric domain.
    Shaw GS; Sykes BD
    Biochemistry; 1996 Jun; 35(23):7429-38. PubMed ID: 8652520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy.
    Moy FJ; Seddon AP; Böhlen P; Powers R
    Biochemistry; 1996 Oct; 35(42):13552-61. PubMed ID: 8885834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of R-elafin, a specific inhibitor of elastase.
    Francart C; Dauchez M; Alix AJ; Lippens G
    J Mol Biol; 1997 May; 268(3):666-77. PubMed ID: 9171290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sweet-tasting protein monellin is related to the cystatin family of thiol proteinase inhibitors.
    Murzin AG
    J Mol Biol; 1993 Mar; 230(2):689-94. PubMed ID: 8464079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
    Pavlova A; Björk I
    Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
    Pol E; Björk I
    Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure and dynamics of rat apo-cellular retinol-binding protein II in solution: comparison with the X-ray structure.
    Lu J; Lin CL; Tang C; Ponder JW; Kao JL; Cistola DP; Li E
    J Mol Biol; 1999 Mar; 286(4):1179-95. PubMed ID: 10047490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.